Literature DB >> 12835874

[The use of neuromuscular monitoring in Germany].

T Fuchs-Buder1, R Hofmockel, G Geldner, C Diefenbach, K Ulm, M Blobner.   

Abstract

AIM: As there are no reliable epidemiological data for the use of muscle relaxants in Germany,we conducted a mailing study. The aim of the study was to compare the use of muscle relaxants between German anaesthesia departments. In the present part of the presentation we focused on neuromuscular monitoring (NMM) and management of residual paralysis.
METHODS: A total number of 2,996 questionnaires were sent to all registered anaesthesiological facilities in Germany and the return was 68.6% (2054 questionnaires).
RESULTS: In 574 of the returned questionnaires (28%) the regular use of NMM was confirmed. Intraoperative monitoring of neuromuscular block and assessment of neuromuscular recovery were the most frequent applications of NMM, i.e. 25% and 18% of returned questionnaires, respectively. Clinical signs, however, are still the most popular way to estimate the degree of neuromuscular blockade. Moreover, routine reversal at the end of surgery with a neostigmin/atropine mixture was not practiced in 75% of the anaesthesia departments.
CONCLUSIONS: This survey revealed that NMM is still very rarely used in daily clinical practice. Especially the seldom use of NMM to assess residual paralysis has to be improved.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12835874     DOI: 10.1007/s00101-003-0508-9

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  11 in total

1.  [Neuromuscular rest blockades after a single dose of a mid-term muscle relaxant].

Authors:  J U Schreiber
Journal:  Anaesthesist       Date:  2004-10       Impact factor: 1.041

Review 2.  [Residual neuromuscular blockades. Clinical consequences, frequency and avoidance strategies].

Authors:  T Fuchs-Buder; M Eikermann
Journal:  Anaesthesist       Date:  2006-01       Impact factor: 1.041

3.  [Application of neuromuscular monitoring in Germany].

Authors:  T Fuchs-Buder; H Fink; R Hofmockel; G Geldner; K Ulm; M Blobner
Journal:  Anaesthesist       Date:  2008-09       Impact factor: 1.041

4.  Use of intraoperative neuromuscular monitor reduces the reversal dose of sugammadex: a single-center retrospective study.

Authors:  Hajime Iwasaki; Atsushi Kurosawa; Takafumi Iida; Tomoki Sasakawa; Hirotsugu Kanda
Journal:  J Anesth       Date:  2020-01-28       Impact factor: 2.078

5.  [Total intravenous anesthesia with propofol and remifentanil. Results of a multicenter study of 6,161 patients].

Authors:  J Schmidt; W Hering; S Albrecht
Journal:  Anaesthesist       Date:  2005-01       Impact factor: 1.041

6.  Lateral spread response monitoring during microvascular decompression for hemifacial spasm. Comparison of two targets of partial neuromuscular blockade.

Authors:  Y H Chung; W H Kim; J J Lee; S-I Yang; S H Lim; D W Seo; K Park; I S Chung
Journal:  Anaesthesist       Date:  2014-02-07       Impact factor: 1.041

7.  A survey of the current use of neuromuscular blocking drugs among the Middle Eastern anesthesiologists.

Authors:  Abdelazeem Eldawlatly; Mohamed R El-Tahan
Journal:  Saudi J Anaesth       Date:  2013-04

8.  The use of sugammadex for bariatric surgery: analysis of recovery time from neuromuscular blockade and possible economic impact.

Authors:  Edoardo De Robertis; Geremia Zito Marinosci; Giovanni Marco Romano; Ornella Piazza; Michele Iannuzzi; Fabrizio Cirillo; Stefania De Simone; Giuseppe Servillo
Journal:  Clinicoecon Outcomes Res       Date:  2016-06-29

9.  Current Trends in Neuromuscular Blockade, Management, and Monitoring amongst Singaporean Anaesthetists.

Authors:  Wendy H Teoh; Thomas Ledowski; Phillip S Tseng
Journal:  Anesthesiol Res Pract       Date:  2016-10-13

10.  Use of neuromuscular blockers and neostigmine for general anesthesia and its association with neuraxial blockade: A retrospective study.

Authors:  Filipe Nadir Caparica Santos; Angélica de Fátima de Assunção Braga; Fernando Eduardo Feres Junqueira; Rafaela Menezes Bezerra; Felipe Ferreira de Almeida; Franklin Sarmento da Silva Braga; Vanessa Henriques Carvalho
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.